ZLAB

Zai Lab (Hong Kong), Ltd.

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

2Trials in this database

5Recorded changes · last 12 months

Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source

Trial	Sponsor	Phase	Status	Primary completion
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPNCT06162286	Zai Lab (Hong Kong), Ltd.	Phase 3	Unknown	2025-01-01Estimated
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque PsoriasisNCT06380907	Zai Lab (Hong Kong), Ltd.	Phase 2	Terminated	2025-12-16Actual

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Zai Lab (Hong Kong), Ltd.UnknownPrimary completion: 2025-01-01 · Estimated

Trial details

Registry ID: NCT06162286
Phase: Phase 3

A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

Zai Lab (Hong Kong), Ltd.TerminatedPrimary completion: 2025-12-16 · Actual

Trial details

Registry ID: NCT06380907
Phase: Phase 2

− Before

~~Recruiting~~

+ After

Terminated

Check registry source